There’s something peculiar about strolling through downtown Indianapolis and discovering that one of the world’s most valuable pharmaceutical companies is…
When HIMS began to tick up in aftermarket trading late on a Friday in early March, it was the first…
Somewhere outside of Montevideo, the lights remain on and the wind farms continue to run during the dry months when…
You’ll notice an odd contradiction if you walk into nearly any mid-sized office right now. The screens have more content.…
The launch took place in Brooklyn, of all places, and Jimmy Fallon warmed up a crowd that, by all accounts,…
AbbVie’s identity was largely dependent on a single molecule for many years. The immunology blockbuster Humira, which was once the…
Over the past year, a certain silence has descended upon the marketing floors of a number of major consumer goods…
Around 3 p.m. Eastern, a Bloomberg terminal has an odd rhythm. The Conference Board confidence number is stuck near pandemic…
The “Help Wanted” sign in the window of a diner on a section of Route 20 outside Rockford, Illinois, was…
The Founder Who Turned Down a $10 Billion Acquisition Offer, Five Years Later, Here Is What Happened
In Silicon Valley, there is a certain kind of moment that very few people openly discuss. A founder, who is…
In March, a picture of a gas station on Sunset Boulevard in Los Angeles with pump prices significantly higher than…
Within Anthropic’s Fifth Street offices in San Francisco, a small team of engineers worked on what they kindly refer to…
